Alavi A - Search Results

1

Stimulating technetium-99m cerebral perfusion studies with a three-dimensional Hoffmann brain phantom: collimator and filter selection in SPECT neuroimaging.

Kim HJ, Karp JS, Mozley PD, Yang SO, Moon DH, Kung HF, Lee HK, Alavi A. Kim HJ, et al. Among authors: alavi a. Ann Nucl Med. 1996 Feb;10(1):153-60. doi: 10.1007/BF03165071. Ann Nucl Med. 1996. PMID: 8814722

2

Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.

Billings JJ, Kung MP, Chumpradit S, Mozley D, Alavi A, Kung HF. Billings JJ, et al. Among authors: alavi a. J Neurochem. 1992 Jan;58(1):227-36. doi: 10.1111/j.1471-4159.1992.tb09300.x. J Neurochem. 1992. PMID: 1530770

3

Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation.

Kohn MI, Tanna NK, Herman GT, Resnick SM, Mozley PD, Gur RE, Alavi A, Zimmerman RA, Gur RC. Kohn MI, et al. Among authors: alavi a. Radiology. 1991 Jan;178(1):115-22. doi: 10.1148/radiology.178.1.1984289. Radiology. 1991. PMID: 1984289

4

In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

Kung HF, Alavi A, Chang W, Kung MP, Keyes JW Jr, Velchik MG, Billings J, Pan S, Noto R, Rausch, et al. Kung HF, et al. Among authors: alavi a. J Nucl Med. 1990 May;31(5):573-9. J Nucl Med. 1990. PMID: 2140408 Free article.

5

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.

Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A. Kung MP, et al. Among authors: alavi a. J Nucl Med. 1990 May;31(5):648-54. J Nucl Med. 1990. PMID: 2140409 Free article.

6

A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH.

Kung HF, Liu BL, Mankoff D, Kung MP, Billings JJ, Francesconi L, Alavi A. Kung HF, et al. Among authors: alavi a. J Nucl Med. 1990 Oct;31(10):1635-40. J Nucl Med. 1990. PMID: 2213185 Free article.

7

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

Kung HF, Pan S, Kung MP, Billings J, Kasliwal R, Reilley J, Alavi A. Kung HF, et al. Among authors: alavi a. J Nucl Med. 1989 Jan;30(1):88-92. J Nucl Med. 1989. PMID: 2783457 Free article.

8

Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features.

Gur RE, Mozley PD, Resnick SM, Mozley LH, Shtasel DL, Gallacher F, Arnold SE, Karp JS, Alavi A, Reivich M, et al. Gur RE, et al. Among authors: alavi a. Arch Gen Psychiatry. 1995 Aug;52(8):657-67. doi: 10.1001/archpsyc.1995.03950200047013. Arch Gen Psychiatry. 1995. PMID: 7632119

9

Sex differences in regional cerebral glucose metabolism during a resting state.

Gur RC, Mozley LH, Mozley PD, Resnick SM, Karp JS, Alavi A, Arnold SE, Gur RE. Gur RC, et al. Among authors: alavi a. Science. 1995 Jan 27;267(5197):528-31. doi: 10.1126/science.7824953. Science. 1995. PMID: 7824953

10

The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma.

Mozley PD, Kim CK, Mohsin J, Jatlow A, Gosfield E 3rd, Alavi A. Mozley PD, et al. Among authors: alavi a. J Nucl Med. 1994 Jul;35(7):1138-44. J Nucl Med. 1994. PMID: 8014671 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,937 results

Search Page

Filters